Lv2
140 积分 2026-02-24 加入
Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature
6天前
已完结
Eculizumab Improves Renal Survival in Complement-Mediated TMA Secondary to SLE
6天前
已完结
Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis
7天前
已完结
Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis
1个月前
已完结
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathy
3个月前
已完结
Eсulizumab in treatment of ANCA-associated vasculitis complicated with Covid-19. Clinical observations
3个月前
已完结
Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report
3个月前
已完结
Publisher's note: Challenges for complement functional assays in the clinical laboratory: From test validation to clinical interpretation
4个月前
已关闭
Ibuprofen-induced HUS
4个月前
已完结
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
4个月前
已完结
皖公网安备34019202002308
